Stocks
Iovance Biotherapeutics (IOVA) EBITDA US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | -328.7 | -377.7 | -427.4 | -351.7 | -357.1 | -326.8 | ||
| Changes by years, y/y, % | +26% | +15% | +13% | -18% | +2% | +6.5% | |||
Iovance Biotherapeutics. EBITDA US GAAP, bln rub
Iovance Biotherapeutics. EBITDA US GAAP, changes, %
Iovance Biotherapeutics. EBITDA US GAAP, sum by quarters, bln rub
Iovance Biotherapeutics (IOVA) EBITDA US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| EBITDA, bln rub | ? | -106.9 | -97.7 | -84.7 | -67.8 | -71.2 | -326.8 | |
| Changes by years, y/y, % | -1% | +7% | +9% | -9% | -33% | |||
| Changes by quarters, q/q, % | +43% | -9% | -13% | -20% | +5% | |||
